JAN 30, 2021 7:41 AM PST

Farming natural killer exosomes to fight cancer

New research published in Advanced Science from scientists at the University of Michigan Rogel Cancer Center and U-M College of Engineering highlights development in cancer-fighting efforts. The research details how the exosomes of natural killer cells (NK cells) can be targeted, harvested, and redirected to attack cancer cells.

"Exosomes are small sacs of proteins and other molecules that are naturally released by almost every type of cell in the body," says co-author Yoon-Tae Kang, Ph.D. "In this case, we wanted to expand our understanding of NK exosomes and try to harness their cancer-killing potential."

Because of their small scale, NK exosomes offer a unique opportunity to infiltrate cancer cells. They are also more stable and easier to modify for therapeutic purposes than NK cells themselves, explain the researchers. To take advantage of this, the group showed that it is possible to capture NK cells on a microfluidic chip from patients with non-small cell lung cancer and use them to "farm" NK exosomes.

"The advantage of exosomes is that they're organic, native to your body," says co-senior study author, Sunitha Nagrath, Ph.D. "We didn't have to fabricate them. The beauty of the approach is being able to capture the NK cells on a microfluidic chip, incubate them on the chip for a short period of time and then collect the exosomes that are released by the cells. Otherwise, trying to isolate exosomes directly from the blood would be like looking for tiny pebbles in a room packed full of stuff."

This is the first study to evaluate the potential of using patient-derived NK cells to produce NK exosomes. The group conducted further experiments to show that these NK exosomes are in fact able to kill circulating tumor cells in cell cultures.

"When we first started on this research, we weren't sure if we were going to be able to generate and harvest the NK exosomes using a chip and ExoBeads," Nagrath says. "Or if we'd be able to collect them efficiently enough for potential therapeutic use. The NK cell capture process, the process of separating the NK exosomes from the beads, creating an assay to evaluate the exosomes' ability to kill cancer cells -- there were many components that had to be optimized for this approach to be a success, and each one presented its own challenges." Nevertheless, with persistence, the team achieved their goal. They hope to continue future investigations in order to develop the technology to make it ready for clinical use.

Sources: Advanced ScienceEureka Alert

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
AUG 29, 2022
Health & Medicine
US-Funded Research to be Open Access by 2026 Under New Federal Guidance
AUG 29, 2022
US-Funded Research to be Open Access by 2026 Under New Federal Guidance
If you have ever done research for school or work, or simply been curious about a scientific finding and wanted to read ...
SEP 25, 2022
Genetics & Genomics
The next generation of library preparation solutions for DNA sequencing
SEP 25, 2022
The next generation of library preparation solutions for DNA sequencing
The next generation of library preparation solutions for DNA sequencing  Since the completion of the Human Genome P ...
OCT 13, 2022
Cancer
Gene Editing Beyond CRISPR-Cas9: Base Editors
OCT 13, 2022
Gene Editing Beyond CRISPR-Cas9: Base Editors
Point mutations change one or very few nucleotides in DNA, but they cause an estimated 30,000 genetic diseases in humans ...
OCT 04, 2022
Cancer
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
OCT 04, 2022
The NCI Welcomes First Woman Director: Monica M. Bertagnolli, MD
In August, President Biden announced his intention to appoint Dr. Monica M. Bertagnolli as the newest director of the Na ...
OCT 06, 2022
Chemistry & Physics
2022 Nobel Prize in Chemistry
OCT 06, 2022
2022 Nobel Prize in Chemistry
It’s that time of year again! Three scientists, Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless, were a ...
Loading Comments...